LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

AB Enzymes joins EuropaBio: Individual Enzyme Solutions for Individual Requirements

14/12/2021
PRESS RELEASE

AB Enzymes joins EuropaBio: Individual Enzyme Solutions for Individual Requirements

Brussels, 14 December 2021 – EuropaBio is pleased to announce that AB Enzymes has joined the association as a corporate member.

With headquarters in Germany, a manufacturing site in Finland and a global presence in more than 60 countries, AB Enzymes is an industrial biotech company specialized in enzymes and their applications in many markets.

Fueled by strong capabilities in innovation, AB Enzymes develops, produces and markets high value enzyme products for a wide range of food and beverages (from enzymes for baking, fruit juice processing, grains and vegetable oil seed processing, protein processing and modification ...), animal feed, and other industrial applications (pulp and paper, textiles and laundry detergents) for customers worldwide.

EuropaBio Director-General Dr. Claire Skentelbery commented “AB Enzymes is an excellent addition to the EuropaBio community and together we will help to rethink the regulatory approach to fermentation products in the EU, turning it into a science-based, transparent, and predictable regulatory framework”.

Martin Klavs Nielsen, CEO at AB Enzymes, added: “We look forward joining EuropaBio as we believe the bio-industry in Europe needs a strong platform to interact with governments and legislators. We need that to convince our stakeholders that the bio-industry has a lot to offer to its customers – innovative, relevant, sustainable products, at an attractive cost-in-use”.

AB Enzymes joins EuropaBio


Download
Share
Communications Team
Communications Team

Related posts

14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.